Jack L. LeFrock

3.1k total citations · 1 hit paper
84 papers, 2.3k citations indexed

About

Jack L. LeFrock is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jack L. LeFrock has authored 84 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmacology, 20 papers in Infectious Diseases and 18 papers in Epidemiology. Recurrent topics in Jack L. LeFrock's work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Antibiotic Resistance in Bacteria (16 papers) and Antimicrobial Resistance in Staphylococcus (15 papers). Jack L. LeFrock is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (31 papers), Antibiotic Resistance in Bacteria (16 papers) and Antimicrobial Resistance in Staphylococcus (15 papers). Jack L. LeFrock collaborates with scholars based in United States, United Kingdom and Switzerland. Jack L. LeFrock's co-authors include Warren S. Joseph, Jon T. Mader, H. Gunner Deery, James S. Tan, Carl W. Norden, Benjamin A. Lipsky, Anthony R. Berendt, John M. Embil, Adolf W. Karchmer and Daniel P. Lew and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Jack L. LeFrock

82 papers receiving 2.0k citations

Hit Papers

Diagnosis and Treatment of Diabetic Foot Infections 2004 2026 2011 2018 2004 250 500 750

Peers

Jack L. LeFrock
James S. Tan United States
Murray A. Abramson United States
Francisco L. Sapico United States
Gregory M. Caputo United States
Hanna N. Canawati United States
Nalini Singh United States
H. Gunner Deery United States
L. Legout France
Warren S. Joseph United States
James S. Tan United States
Jack L. LeFrock
Citations per year, relative to Jack L. LeFrock Jack L. LeFrock (= 1×) peers James S. Tan

Countries citing papers authored by Jack L. LeFrock

Since Specialization
Citations

This map shows the geographic impact of Jack L. LeFrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack L. LeFrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack L. LeFrock more than expected).

Fields of papers citing papers by Jack L. LeFrock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack L. LeFrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack L. LeFrock. The network helps show where Jack L. LeFrock may publish in the future.

Co-authorship network of co-authors of Jack L. LeFrock

This figure shows the co-authorship network connecting the top 25 collaborators of Jack L. LeFrock. A scholar is included among the top collaborators of Jack L. LeFrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack L. LeFrock. Jack L. LeFrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lipsky, Benjamin A., Anthony R. Berendt, H. Gunner Deery, et al.. (2006). Diagnosis and Treatment of Diabetic Foot Infections. Plastic & Reconstructive Surgery. 117(SUPPLEMENT). 212S–238S. 267 indexed citations
2.
Lipsky, Benjamin A., Anthony R. Berendt, H. Gunner Deery, et al.. (2005). Diagnosis and Treatment of Diabetic Foot Infections. Journal of the American Podiatric Medical Association. 95(2). 183–210. 13 indexed citations
3.
LeFrock, Jack L. & Angela M. Ristuccia. (1999). Teicoplanin in the treatment of bone and joint infections: An open study. Journal of Infection and Chemotherapy. 5(1). 32–39. 26 indexed citations
4.
Joseph, Warren S. & Jack L. LeFrock. (1996). THE USE OF ORAL ANTIBIOTICS IN LOWER-EXTREMITY INFECTIONS. Clinics in Podiatric Medicine and Surgery. 13(4). 683–699. 2 indexed citations
5.
Poindexter, Alfred N., Sebastian Faro, Michael A. Castellano, et al.. (1988). Results of noncomparative studies of cefotetan in the treatment of obstetric and gynecologic infections. American Journal of Obstetrics and Gynecology. 158(3). 717–721. 11 indexed citations
6.
Geckler, Ronald W., Robert H.K. Eng, Timothy C. Fabian, et al.. (1988). A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superificial soft tissue. The American Journal of Surgery. 155(5). 91–95. 5 indexed citations
7.
Rolston, K. V. I., et al.. (1985). Clinical features and antimicrobial therapy of infections caused by group G streptococci. Infection. 13(5). 203–206. 8 indexed citations
8.
Chandrasekar, Pranatharthi, et al.. (1984). Enterococcal superinfection and colonization with aztreonam therapy. Antimicrobial Agents and Chemotherapy. 26(2). 280–282. 35 indexed citations
9.
LeFrock, Jack L., et al.. (1984). Management of osteomyelitis and soft-tissue infections.. PubMed. 56(5). 289–96. 1 indexed citations
10.
Smith, Bruce R. & Jack L. LeFrock. (1983). Cefuroxime. Therapeutic Drug Monitoring. 5(2). 149–160. 28 indexed citations
11.
Schell, Ronald F., et al.. (1983). Detection and quantitation of simulated anaerobic bacteremia by centrifugation and filtration. Journal of Clinical Microbiology. 17(5). 856–859. 10 indexed citations
12.
Schell, Ronald F., et al.. (1983). In vitro Antimicrobial Activity of Ceftizoxime. Chemotherapy. 29(6). 408–414. 2 indexed citations
13.
Schell, Ronald F., Jack L. LeFrock, & John Chan. (1982). Transfer of resistance with syphilitic immune cells: lack of correlation with mitogenic activity. Infection and Immunity. 35(1). 187–192. 1 indexed citations
14.
Mader, Jon T., et al.. (1982). Cefotaxime Therapy for Patients with Osteomyelitis and Septic Arthritis. Clinical Infectious Diseases. 4(Supplement_2). S472–S480. 19 indexed citations
15.
LeFrock, Jack L., et al.. (1982). Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections. Journal of Antimicrobial Chemotherapy. 10(suppl C). 215–221. 5 indexed citations
16.
LeFrock, Jack L., et al.. (1982). Cefoxitin Therapy in Aerobic, Anaerobic, and Mixed Aerobic-Anaerobic Infections. Drug Intelligence & Clinical Pharmacy. 16(4). 306–312. 6 indexed citations
17.
Miller, Marcia A., et al.. (1981). Comparative Activity of N‐Formimidoyl Thienamycin with Third Generation Cephalosporins and Ureido Penicillins against Multiple Resistant Serratia marcescens. Microbiology and Immunology. 25(11). 1119–1127. 4 indexed citations
18.
Schell, Ronald F., Jack L. LeFrock, John Chan, & Omar Bagasra. (1981). LSH Hamster Model of Syphilitic Infection and Transfer of Resistance with Immune T Cells. Advances in experimental medicine and biology. 134. 291–300. 11 indexed citations
19.
Chan, John, Ronald F. Schell, & Jack L. LeFrock. (1979). Inability of immune cells treated with anti-thymocyte serum to confer on hamsters resistance to cutaneous infection with Treponema pertenue. Infection and Immunity. 25(1). 208–212. 2 indexed citations
20.
LeFrock, Jack L., et al.. (1973). Transient Bacteremia Associated with Sigmoidoscopy. New England Journal of Medicine. 289(9). 467–469. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026